David Hallal, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,014 shares at $138.91 ($280K) on 2016-02-29, disclosed to the SEC on 2016-03-01.
Open-market sale of $280k ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.91 | 2,000 | $278K | 99.3% |
| 2 | $141.45 | 14 | $2K | 0.7% |
| Total | $138.93 avg | 2,014 | $280K | 100% |
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |